Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-FAPI-04 vs 18F-FDG PET-CT in Pulmonary Fibrosis
NCT05121779Phase 1Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Nov 2021
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of 68Ga-FAPI-4 in pulmonary fibrosis (PF), sponsored by Peking Union Medical College Hospital. Primary endpoint: Diagnostic value at 1 year. Started Nov 2021; status: recruiting.
02
Drugs
68Ga-FAPI-4
03
Conditions
pulmonary fibrosis (PF)
Beyond the preview
Go deeper on NCT05121779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05121779.